RARE
Ultragenyx Pharmaceutical Inc.
NASDAQ · Healthcare · Biotechnology · US
$15.40
+3.70%Leverage
- Debt / equity
- -4.13x
- Net debt / equity
- -3.70x
- Debt / assets
- 0.95x
- Debt / EBITDA
- -2.54x
- Net debt / EBITDA
- -2.28x
Liquidity & coverage
- Current ratio
- 1.73x
- Quick ratio
- 1.56x
- Cash ratio
- 0.83x
- Interest coverage
- -6.95x
- EBITDA / interest
- -6.21x
- Working capital
- $255.0M
Cash & dividend
- FCF / debt
- -0.41x
- Cash flow / debt
- -0.40x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026